Ignite Creation Date:
2024-05-06 @ 9:33 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03017820
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2017-01-09
Brief Title:
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma Acute Myeloid Leukemia or Lymphoma
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory T-Cell Non-Hodgkin Lymphoma |
| B-Cell Non-Hodgkin Lymphoma |
| Histiocytic and Dendritic Cell Neoplasm |
| Myelodysplastic Syndrome |
| Previously Treated Myelodysplastic Syndrome |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Anaplastic Large Cell Lymphoma |
| Recurrent Angioimmunoblastic T-Cell Lymphoma |
| Recurrent Mycosis Fungoides |
| Recurrent Plasma Cell Myeloma |
| Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma |
| Recurrent T-Cell Non-Hodgkin Lymphoma |
| Refractory Acute Myeloid Leukemia |
| Refractory Anaplastic Large Cell Lymphoma |
| Refractory Angioimmunoblastic T-Cell Lymphoma |
| Refractory Mycosis Fungoides |
| Refractory Peripheral T-Cell Lymphoma Not Otherwise Specified |
| Refractory Plasma Cell Myeloma |
| Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma |
Keywords: